Scott Michael Habig - 01 Aug 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Commercial Officer
Signature
/s/ Scott Habig
Issuer symbol
AUPH
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
4
Filing time
01 Aug 2022, 16:13:22 UTC
Previous filing
19 Jul 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Stock Option (right to buy) Award $0 +231,203 $0.000000 231,203 01 Aug 2022 Common Stock 231,203 $8.18 Direct F1
transaction AUPH Restricted Stock Units Award $0 +137,531 $0.000000 137,531 01 Aug 2022 Common Shares 137,531 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023.